Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

The hospital operator will invest more in organic hospital growth and high-acuity service lines as it sees strong demand for ...

The partnership with Noom aims to cut costs by treating weight management as preventative healthcare. Nearly 2 million ...

Dr. Cliff Deveny announced the transition less than a month after General Catalyst finalized its $515 million acquisition of Summa.

The Tennessee-based health system will continue to sell hospitals as it looks to focus more on capital-efficient outpatient ...

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

Measuring financial returns from AI can be challenging, experts said at the HLTH conference last week. But other metrics, ...

Overall, Cigna expects earnings to grow next year after posting a solid third quarter. But investments in a new PBM model and ...

Fewer than 30% of health system leaders said they earned significant return on investment from virtual care offerings, ...

The goodwill impairment charge is meant to realign Centene’s value on its own books with it value in the market, which has ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

The company has started to score insurers on their success in making rate data available online. Large payers tend to do ...